(Q35593901)

9 August 2017

1 reference

title

Safety of new phosphate binders for chronic renal failure (English)

1 reference

9 August 2017

Mahmoud Loghman-Adham

series ordinal

1

1 reference

9 August 2017

1 January 2003

1 reference

9 August 2017

1 reference

9 August 2017

26

1 reference

9 August 2017

15

1 reference

9 August 2017

1093-1115

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200326150-00003

9 August 2017

0 references

cites work

Phosphate dialytic removal: enhancement of phosphate cellular clearance by biofiltration (with acetate-free buffer dialysate)

1 reference

12 December 2020

Calcium carbonate: a suitable alternative to aluminum hydroxide as phosphate binder

1 reference

12 December 2020

Management of hyperphosphataemia of chronic kidney disease: lessons from the past and future directions

1 reference

12 December 2020

Behaviour of phosphate removal with different dialysis schedules

1 reference

12 December 2020

The Noncalcemic Analogue of Vitamin D, 22-Oxacalcitriol, Suppresses Parathyroid Hormone Synthesis and Secretion

1 reference

12 December 2020

Influence of calcium acetate or calcium citrate on intestinal aluminum absorption

1 reference

12 December 2020

Lead content of calcium supplements

1 reference

12 December 2020

The Treatment of Uraemic Hyperphosphataemia with Calcium Acetate and Calcium Carbonate: A Comparative Study

1 reference

12 December 2020

Minimising the dosage-limiting toxicities of foscarnet induction therapy

1 reference

12 December 2020

RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group

1 reference

12 December 2020

Phosphate kinetics in dialysis patients

1 reference

12 December 2020

Effect of oral citrate on calcium absorption after an oral load of calcium phosphate

1 reference

12 December 2020

Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients

1 reference

12 December 2020

Possible role of nicotinamide adenine dinucleotide as an intracellular regulator of renal transport of phosphate in the rat

1 reference

12 December 2020

Aluminium intoxication in renal disease

1 reference

12 December 2020

Efficacy and safety of long-term treatment with calcium carbonate as a phosphate binder

1 reference

12 December 2020

Phosphorus kinetics during haemodialysis and haemofiltration

1 reference

12 December 2020

Effects of aspirin upon the flushing reaction induced by niceritrol

1 reference

12 December 2020

Progressive dialysis encephalopathy from dialysate aluminum

1 reference

12 December 2020

Neurodevelopmental effects of lanthanum in mice.

1 reference

12 December 2020

New phosphate binding agents: ferric compounds

1 reference

12 December 2020

Calcium acetate versus calcium carbonate as phosphorus binders in patients on chronic haemodialysis: a controlled study

1 reference

12 December 2020

Calcium citrate, a nonaluminum-containing phosphate-binding agent for treatment of CRF

1 reference

12 December 2020

A possible non-aluminum oral phosphate binder? A comparative study on dietary phosphorus absorption

1 reference

12 December 2020

Aluminium intoxication in undialysed adults with chronic renal failure

1 reference

12 December 2020

Citrate: a major factor in the toxicity of orally administered aluminum compounds

1 reference

12 December 2020

Prevalence and clinical consequences of elevated Ca x P product in hemodialysis patients.

1 reference

12 December 2020

19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis

1 reference

12 December 2020

Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients

1 reference

12 December 2020

Daily hemodialysis: an update

1 reference

12 December 2020

Effect of phosphate binders on supplemental iron absorption in healthy subjects

1 reference

12 December 2020

Alternative phosphate binders in dialysis patients: calcium carbonate

1 reference

12 December 2020

Phosphate kinetics during hemodialysis: Evidence for biphasic regulation

1 reference

12 December 2020

Secondary hyperparathyroidism in renal failure: the trade-off hypothesis revisited

1 reference

12 December 2020

Effect of aluminum on hematopoiesis

1 reference

12 December 2020

Long-term use of magnesium hydroxide as a phosphate binder in patients on hemodialysis

1 reference

12 December 2020

The effect of a high intake of calcium carbonate in normal subjects and patients with chronic renal failure

1 reference

12 December 2020

Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis

1 reference

12 December 2020

Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis

1 reference

12 December 2020

Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management

1 reference

12 December 2020

A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients

1 reference

12 December 2020

Nocturnal hemodialysis: three-year experience.

1 reference

12 December 2020

Nocturnal home haemodialysis: an update on a 5-year experience.

1 reference

12 December 2020

Calcium acetate versus calcium carbonate as oral phosphate binder in pediatric and adolescent hemodialysis patients

1 reference

12 December 2020

Slowing the progression of vascular calcification in hemodialysis

1 reference

12 December 2020

Adaptation to changes in dietary phosphorus intake in health and in renal failure

1 reference

12 December 2020

Variable efficacy of calcium carbonate tablets

1 reference

12 December 2020

Calcium alpha-ketoglutarate administration to malnourished hemodialysis patients improves plasma arginine concentrations.

1 reference

12 December 2020

Toxicological and cytophysiological aspects of lanthanides action

1 reference

12 December 2020

The use of magnesium-containing phosphate binders in patients with end-stage renal disease on maintenance hemodialysis

1 reference

12 December 2020

Phosphonocarboxylic acids as specific inhibitors of Na+-dependent transport of phosphate across renal brush border membrane

1 reference

12 December 2020

On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog

1 reference

12 December 2020

Osteomalacia in chronic renal failure: a syndrome previously reported only with maintenance dialysis

1 reference

12 December 2020

The development and in-vitro evaluation of novel mixed metal hydroxy-carbonate compounds as phosphate binders

1 reference

12 December 2020

Aluminum loading in children with chronic renal failure

1 reference

12 December 2020

Long-term effects of calcium carbonate and 2.5 mEq/liter calcium dialysate on mineral metabolism

1 reference

12 December 2020

Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function

1 reference

12 December 2020

A prospective study of combination therapy for hyperphosphataemia with calcium-containing phosphate binders and sevelamer in hypercalcaemic haemodialysis patients

1 reference

12 December 2020

The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism

1 reference

12 December 2020

High frequency of iron bone deposits in a Mexican population with renal osteodystrophy

1 reference

12 December 2020

Calcium acetate control of serum phosphorus in hemodialysis patients

1 reference

12 December 2020

Simultaneous lowering of serum phosphate and LDL-cholesterol by sevelamer hydrochloride (RenaGel) in dialysis patients

1 reference

12 December 2020

Calcium acetate versus calcium carbonate as phosphate-binding agents in chronic haemodialysis

1 reference

12 December 2020

Cross-linking chitosan-Fe(III), an oral phosphate binder: studies in vitro and in vivo

1 reference

12 December 2020

Different Mg to Fe ratios in the mixed metal MgFe hydroxy-carbonate compounds and the effect on phosphate binding compared with established phosphate binders

1 reference

12 December 2020

Calcium carbonate is an effective phosphate binder when dialysate calcium concentration is adjusted to control hypercalcemia

1 reference

12 December 2020

Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients

1 reference

12 December 2020

Serum magnesium level and arterial calcification in end-stage renal disease

1 reference

12 December 2020

Cytotoxicity of the rare earth metals cerium, lanthanum, and neodymium in vitro: comparisons with cadmium in a pulmonary macrophage primary culture system

1 reference

12 December 2020

Calcium carbonate is an effective phosphorus binder in children with chronic renal failure

1 reference

12 December 2020

Phosphate binders for control of phosphate retention in chronic renal failure

1 reference

12 December 2020

Visceral calcification and the CaXP product

1 reference

12 December 2020

Ranitidine reduces phosphate binding in dialysis patients receiving calcium carbonate

1 reference

12 December 2020

Phosphate kinetics during high-flux hemodialysis

1 reference

12 December 2020

Effect of solubility on the gastrointestinal absorption of aluminum from various aluminum compounds in the rat

1 reference

12 December 2020

The absorption of dietary phosphorus and calcium in hemodialysis patients

1 reference

12 December 2020

Safety and efficacy of calcium carbonate in children with chronic renal failure

1 reference

12 December 2020

Role of calcium carbonate administration timing in relation to food intake on its efficiency in controlling hyperphosphatemia in patients on maintenance dialysis

1 reference

12 December 2020

Neurotoxicity of lanthanum chloride in newborn chicks

1 reference

12 December 2020

Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD.

1 reference

12 December 2020

Transient decrease of serum bicarbonate levels with Sevelamer hydrochloride as the phosphate binder

1 reference

12 December 2020

Phosphate binders on iron basis: a new perspective?

1 reference

12 December 2020

Substitution of aluminium hydroxide by high doses of calcium carbonate in patients on chronic haemodialysis: disappearance of hyperaluminaemia and equal control of hyperparathyroidism

1 reference

12 December 2020

Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure

1 reference

12 December 2020

Gastric acid secretion and serum gastrin levels in patients with chronic renal failure on regular hemodialysis

1 reference

12 December 2020

Clinical outcome of daily dialysis

1 reference

12 December 2020

Substitution of aluminium salts by magnesium salts in control of dialysis hyperphosphataemia

1 reference

12 December 2020

Hyperaluminaemia from aluminum resins in renal failure.

1 reference

12 December 2020

Phosphate removal rate: a comparative study of five high-flux dialysers

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia

1 reference

12 December 2020

High-dose calcium carbonate with stepwise reduction in dialysate calcium concentration: effective phosphate control and aluminium avoidance in haemodialysis patients.

1 reference

12 December 2020

Cross-linked iron dextran is an efficient oral phosphate binder in the rat

1 reference

12 December 2020

Reduction of dietary phosphorus absorption by oral phoshorus binders

1 reference

12 December 2020

Phosphate removal during hemodialysis, hemodiafiltration, and hemofiltration. A reappraisal

1 reference

12 December 2020

Thrombocytopenia and anemia induced by niceritrol used for amelioration of hyperphosphatemia in a hemodialysis patient

1 reference

12 December 2020

Calcium acetate versus calcium carbonate as phosphate binders in hemodialysis patients

1 reference

12 December 2020

An open-label, crossover study of a new phosphate-binding agent in haemodialysis patients: ferric citrate

1 reference

12 December 2020

Role of phosphate retention in the progression of renal failure

1 reference

12 December 2020

Intestinal absorption of magnesium from food and supplements

1 reference

12 December 2020

Estimating phosphate removal in haemodialysis: an additional tool to quantify dialysis dose

1 reference

12 December 2020

Accumulation of aluminum in a nondialyzed uremic child receiving aluminum hydroxide

1 reference

12 December 2020

Molecular mechanisms in proximal tubular and small intestinal phosphate reabsorption (plenary lecture).

1 reference

12 December 2020

Aluminum and lead absorption from dietary sources in women ingesting calcium citrate

1 reference

12 December 2020

Significant myoglobin removal during continuous veno-venous haemofiltration using F80 membrane

1 reference

12 December 2020

Soft tissue calcification in pediatric patients with end-stage renal disease

1 reference

12 December 2020

Influence of pH on in vitro disintegration of phosphate binders

1 reference

12 December 2020

Sevelamer hydrochloride (Renagel), a non-calcaemic phosphate binder, arrests parathyroid gland hyperplasia in rats with progressive chronic renal insufficiency

1 reference

12 December 2020

Calcium acetate as a phosphorus binder in hemodialysis patients

1 reference

12 December 2020

Update on phosphate binders

1 reference

12 December 2020

Aluminum and chronic renal failure: sources, absorption, transport, and toxicity

1 reference

12 December 2020

The use of calcium carbonate to treat the hyperphosphataemia of chronic renal failure

1 reference

12 December 2020

Enhanced calcium bioavailability from a solubilized form of calcium citrate

1 reference

12 December 2020

The potential role of aluminium in Alzheimer's disease

1 reference

12 December 2020

On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using “proportional reduction” of dietary phosphorus intake

1 reference

12 December 2020

Compounds in development to combat hyperphosphataemia

1 reference

12 December 2020

Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study

1 reference

12 December 2020

Bile acid binding to sevelamer HCl.

1 reference

12 December 2020

Inhibition of gastric secretion by omeprazole and efficiency of calcium carbonate on the control of hyperphosphatemia in patients on chronic hemodialysis

1 reference

12 December 2020

The anti-platelet effect of niceritrol in patients with arteriosclerosis and the relationship of the lipid-lowering effect to the anti-platelet effect.

1 reference

12 December 2020

Niceritrol reduces plasma lipoprotein(a) levels in patients undergoing maintenance hemodialysis.

1 reference

12 December 2020

Calcium acetate, an effective phosphorus binder in patients with renal failure

1 reference

12 December 2020

Effect of RenaGel, a non-absorbable, cross-linked, polymeric phosphate binder, on urinary phosphorus excretion in rats

1 reference

12 December 2020

The impact of improved phosphorus control: use of sevelamer hydrochloride in patients with chronic renal failure

1 reference

12 December 2020

Low calcium dialysate and hyperparathyroidism

1 reference

12 December 2020

Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients

1 reference

12 December 2020

Soft-Tissue Calcification in Uremia

1 reference

12 December 2020

Effect of chitosan on renal function in patients with chronic renal failure

1 reference

12 December 2020

Urea, creatinine and phosphate kinetic modeling during dialysis: application to pediatric hemodialysis.

1 reference

12 December 2020

A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients

1 reference

12 December 2020

Nicotinamide inhibits sodium-dependent phosphate cotransport activity in rat small intestine.

1 reference

12 December 2020

Aluminium and bone disease in chronic renal failure

1 reference

12 December 2020

Randomized crossover study comparing the phosphate-binding efficacy of calcium ketoglutarate versus calcium carbonate in patients on chronic hemodialysis

1 reference

12 December 2020

Effects of niceritrol on faecal and urinary phosphate excretion in normal rats

1 reference

12 December 2020

Phosphate-binding capacity of ferrihydrite versus calcium acetate in rats

1 reference

12 December 2020

Sevelamer, a phosphate-binding polymer, is a non-absorbed compound

1 reference

12 December 2020

Long-term treatment with calcium-alpha-ketoglutarate corrects secondary hyperparathyroidism

1 reference

12 December 2020

Hemeral (daily) hemodialysis

1 reference

12 December 2020

Sevelamer reduces calcium load and maintains a low calcium-phosphorus ion product in dialysis patients

1 reference

12 December 2020

Effect of sorbitol on the phosphate adsorptive capacity of ferrihydrite suspensions

1 reference

12 December 2020

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

1 reference

12 December 2020

Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis

1 reference

12 December 2020

A study of the basic principles determining the performance of several high-flux dialyzers

1 reference

12 December 2020

Control of predialytic hyperphosphatemia by oral calcium acetate and calcium carbonate. Comparable efficacy for half the dose of elemental calcium given as acetate without lower incidence of hypercalcemia

1 reference

12 December 2020

Oral phosphate binders: phosphate binding capacity of iron (III) hydroxide complexes containing saccharides and their effect on the urinary excretion of calcium and phosphate in rats

1 reference

12 December 2020

Site and mechanism of enhanced gastrointestinal absorption of aluminum by citrate

1 reference

12 December 2020

Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease

1 reference

12 December 2020

Pathogenesis of secondary hyperparathyroidism

1 reference

12 December 2020

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

1 reference

12 December 2020

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

1 reference

12 December 2020

Stabilized polynuclear iron hydroxide is an efficient oral phosphate binder in uraemic patients.

1 reference

12 December 2020

Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients.

1 reference

12 December 2020

The dialysis encephalopathy syndrome. Possible aluminum intoxication

1 reference

12 December 2020

Low-calcium dialysis fluid and oral calcium carbonate in CAPD. A method of controlling hyperphosphataemia whilst minimizing aluminium exposure and hypercalcaemia

1 reference

12 December 2020

A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients

1 reference

12 December 2020

Inorganic phosphate removal during different dialytic procedures

1 reference

12 December 2020

The evaluation of novel mixed metal hydroxy-carbonates as phosphate binders: an in-vivo study in the rat.

1 reference

12 December 2020

Effect of iron(III) chitosan intake on the reduction of serum phosphorus in rats

1 reference

12 December 2020

Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities

1 reference

12 December 2020

Evidence that resistance to the calcemic action of parathyroid hormone in rats with acute uremia is caused by phosphate retention

1 reference

12 December 2020

Hypophosphatemia induced by intravenous administration of Saccharated iron oxide

1 reference

12 December 2020

Preservation of function in experimental renal disease by dietary restriction of phosphate

1 reference

12 December 2020

Characterization and extracorporeal application of a new phosphate-binding agent

1 reference

12 December 2020

A phosphorylated phloretin derivative. Synthesis and effect on intestinal Na(+)-dependent phosphate absorption

1 reference

12 December 2020

Magnesium carbonate as a phosphorus binder: a prospective, controlled, crossover study

1 reference

12 December 2020

The effects of calcium carbonate as the sole phosphate binder in combination with low calcium dialysate and calcitriol therapy in chronic hemodialysis patients

1 reference

12 December 2020

Reversible microcytic hypochromic anaemia in dialysis patients due to aluminium intoxication

1 reference

12 December 2020

Substitution of calcium carbonate for aluminum hydroxide in patients on hemodialysis. Effects on acidosis, on parathyroid function, and on calcemia

1 reference

12 December 2020

Effect of RenaGel, a non-absorbed, calcium- and aluminium-free phosphate binder, on serum phosphorus, calcium, and intact parathyroid hormone in end-stage renal disease patients

1 reference

12 December 2020

Magnesium hydroxide as a complementary aluminium-free phosphate binder to moderate doses of oral calcium in uraemic patients on chronic haemodialysis: lack of deleterious effect on bone mineralisation

1 reference

12 December 2020

Effects of oral calcium carbonate on control of serum phosphorus and changes in plasma aluminum levels after discontinuation of aluminum-containing gels in children receiving dialysis

1 reference

12 December 2020

Calcium ketoglutarate versus calcium acetate for treatment of hyperphosphataemia in patients on maintenance haemodialysis: a cross-over study

1 reference

12 December 2020

Hemodialysis encephalopathy with osteomalacic fractures and muscle weakness

1 reference

12 December 2020

Effect of ferric polymaltose complex as a phosphate binder in haemodialysis patients

1 reference

12 December 2020

Long-term (6 months) cross-over comparison of calcium acetate with calcium carbonate as phosphate binder

1 reference

12 December 2020

Calcimimetics with potent and selective activity on the parathyroid calcium receptor

1 reference

12 December 2020

Correcting acidosis in hemodialysis: effect on phosphate clearance and calcification risk

1 reference

12 December 2020

Aluminium-induced anaemia in haemodialysis patients

1 reference

12 December 2020

Efficacy and tolerance of three different calcium acetate formulations in hemodialysis patients

1 reference

12 December 2020

Acute aluminum toxicity associated with oral citrate and aluminum-containing antacids

1 reference

12 December 2020

RenaGel, a novel calcium- and aluminium-free phosphate binder, inhibits phosphate absorption in normal volunteers

1 reference

12 December 2020

Use of phosphonoformic acid to induce phosphaturia in chronic renal failure in rats

1 reference

12 December 2020

Oral aluminum toxicity in a non-dialyzed patient with renal failure

1 reference

12 December 2020

Is it possible to control hyperphosphataemia with diet, without inducing protein malnutrition?

1 reference

12 December 2020

Accelerated atherosclerosis, dyslipidemia, and oxidative stress in end-stage renal disease

1 reference

12 December 2020

10.2165/00002018-200326150-00003

Identifiers

DOI

1 reference

PubMed ID

14640773

Dimensions Publication ID

9 August 2017

0 references

1 reference

PubMed ID

14640773